Brainstorm Cell Therapeutics, Inc. (BCLI)
0.98
-0.08
(-7.55%)
USD |
OTCM |
Aug 21, 16:00
Brainstorm Cell Therapeutics Max Drawdown (5Y) : 43.45% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 43.45% |
| June 30, 2026 | 43.45% |
| May 31, 2026 | 43.45% |
| April 30, 2026 | 43.45% |
| March 31, 2026 | 43.45% |
| February 28, 2026 | 43.45% |
| January 31, 2026 | 35.71% |
| December 31, 2025 | 34.17% |
| November 30, 2025 | 30.96% |
| October 31, 2025 | 30.96% |
| September 30, 2025 | 30.96% |
| August 31, 2025 | 30.96% |
| July 31, 2025 | 20.21% |
| June 30, 2025 | 76.30% |
| May 31, 2025 | 76.30% |
| April 30, 2025 | 76.30% |
| March 31, 2025 | 76.30% |
| February 28, 2025 | 76.30% |
| January 31, 2025 | 76.30% |
| December 31, 2024 | 76.30% |
| November 30, 2024 | 76.30% |
| October 31, 2024 | 76.30% |
| September 30, 2024 | 76.30% |
| August 31, 2024 | 76.30% |
| July 31, 2024 | 76.30% |
| Date | Value |
|---|---|
| June 30, 2024 | 76.30% |
| May 31, 2024 | 76.30% |
| April 30, 2024 | 76.30% |
| March 31, 2024 | 76.30% |
| February 29, 2024 | 76.30% |
| January 31, 2024 | 76.30% |
| December 31, 2023 | 76.30% |
| November 30, 2023 | 76.30% |
| October 31, 2023 | 76.30% |
| September 30, 2023 | 76.30% |
| August 31, 2023 | 76.30% |
| July 31, 2023 | 76.30% |
| June 30, 2023 | 76.30% |
| May 31, 2023 | 76.30% |
| April 30, 2023 | 76.30% |
| March 31, 2023 | 76.30% |
| February 28, 2023 | 76.30% |
| January 31, 2023 | 76.30% |
| December 31, 2022 | 76.30% |
| November 30, 2022 | 76.30% |
| October 31, 2022 | 76.30% |
| September 30, 2022 | 76.30% |
| August 31, 2022 | 76.30% |
| July 31, 2022 | 76.30% |
| June 30, 2022 | 76.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| NovelStem International Corp. | 97.80% |
| Summit Therapeutics, Inc. | 95.40% |
| Kezar Life Sciences, Inc. | 98.04% |
| Protara Therapeutics, Inc. | 99.25% |
| Clene, Inc. | 99.27% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -24.61 |
| Beta (5Y) | -0.5099 |
| Historical Sortino (5Y) | -0.3114 |